2022     Every month, we share articles from the MASCC journal Supportive Care in Cancer. The “Editor’s Pick” section, chosen by the journal’s Editor-In-Chief, Dr. Fred Ashbury, PhD, will cover a variety of topics to meet the many interests of our membership. This month we feature:

2022     We’re gathering feedback from our stakeholders (both members and non-members) to help us improve our services. Please share your opinions with us by completing this anonymous survey. 

2022     The MASCC Antiemesis Tool (MAT) has recently been translated into Filipino, thanks to Marvin Jonne L. Mendoza MD, John Paulo B. Vergara MD, Danielle Benedict L. Sacdalan MD, Madelaine A. Amante MD, and Joey A. Tabula MD, on behalf of the Philippine Society of Medical Oncology.  

2022      Every month, we share articles from the MASCC journal Supportive Care in Cancer. The “Editor’s Pick” section, chosen by the journal’s Editor-In-Chief, Dr Fred Ashbury, PhD, will cover a variety of topics to meet the many interests of our membership. This month we feature:

2021      Every month, we share articles from the MASCC journal Supportive Care in Cancer. The “Editor’s Pick” section, chosen by the journal’s Editor-In-Chief, Dr Fred Ashbury, PhD, will cover a variety of topics to meet the many interests of our membership. This month we feature:

2021     Dr Snežana Bošnjak, president of the Serbian Association for Supportive Care in Cancer (SASCC), recently published an informative article on supportive cancer care in Serbia as part of the Cancer in My Community blog series on Cancer.Net. Dr Bošnjak writes:

2021      Every month, we share articles from the MASCC journal Supportive Care in Cancer. The “Editor’s Pick” section, chosen by the journal’s Editor-In-Chief, Dr Fred Ashbury, PhD, will cover a variety of topics to meet the many interests of our membership. This month we feature:

2021    MASCC is developing a strategy to engage people affected by cancer. Interestingly, there is no consistent language existing across geographical distinctions, with reference to a ‘consumer’, ‘patient advocate’ or other similar term. MASCC is conducting a global survey to hear from patient advocates/consumers about what matters most with language use as well as to understand what people see as effective engagement.

2021     The Palliative Care Study Group recently formed a Subgroup to develop evidence-based guidance on the use of clinically assisted nutrition (CAN) in patients with advanced cancer. Although every patient needs individualized management, this guidance will provide a framework for clinicians in this area.

2019    MASCC has just signed an affiliate agreement with the Associação de Investigação e Cuidados de Suporte em Oncologia (AICSO), the Oncology Supportive Care Research Association in Portugal. AICSO Board member Dr. Andreia Capela has been instrumental in bringing about this partnership, which will increase the memberships of both organizations, support collaboration, and help to promote the goals of supportive care in cancer. AICSO, founded in 2001, is a nonprofit, public interest institution. Its aim is the integration of supportive care resources for cancer patients all along the cancer continuum. In recent years, the organization has been active in promoting an active lifestyle for all patients living with and beyond cancer. To meet its goals, AICSO promotes research programs and professional development in supportive cancer care, as well as helping to educate the public about the importance of supportive care for all cancer patients and survivors. AICSO is led by President Dr. Ana Joaquim and Vice-President Dr. Sandra Custódio who, as well as Dr. Capela, are medical oncologists. Find out more at http://www.aicso.pt.

2021     We’re delighted to announce that our journal Supportive Care in Cancer has received a 2020 Impact Factor of 3.603. Congratulations to our Editor-in-Chief Dr Fred Ashbury and all our contributors!

2021     Two updated MASCC guidelines from the Palliative Care Study Group are now available on our website:

2021      Every month, we share articles from the MASCC journal Supportive Care in Cancer. The “Editor’s Pick” section, chosen by the journal’s Editor-In-Chief, Dr Fred Ashbury, PhD, will cover a variety of topics to meet the many interests of our membership. This month we feature:

2021     Our newest guidelines, created jointly with ISOO and ASCO, address the prevention and management of salivary gland hypofunction and xerostomia induced by non-surgical cancer therapies.

2021      Every month, we share articles from the MASCC journal Supportive Care in Cancer. The “Editor’s Pick” section, chosen by the journal’s Editor-In-Chief, Dr Fred Ashbury, PhD, will cover a variety of topics to meet the many interests of our membership. This month we feature:

2021     Coming soon! Edited by MASCC’s own Maryam Lustberg and Charles Loprinzi, this book will be an essential resource for researchers and healthcare providers working with patients experiencing chemotherapy-induced peripheral neuropathy (CIPN).

2021     Our Oncodermatology Study Group is excited to announce the creation of a new Working Group on patient-reported symptom monitoring led by Dr Iris Walraven and Dr Corina van den Hurk.

2021    Every month, we share articles from the MASCC journal Supportive Care in Cancer. The “Editor’s Pick” section, chosen by the journal’s Editor-In-Chief, Dr. Fred Ashbury, PhD, will cover a variety of topics to meet the many interests of our membership. 

2021      The MASCC Survivorship Study Group is working on a follow-up to their article published in Supportive Care in Cancer 28(8): 3845-3488. Part 1 of this project includes a large overview of systematic reviews involving over 20 members within the Survivorship Group. Part 2 of the project will include development MASCC Guidance for the use of telemedicine in cancer survivorship. This work is particularly relevant for supportive care delivery and research in the post-COVID era.